Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-01 · accession 0001439222-23-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-14 | 2023-02-14 | AGIO | Washburn Theodore James Jr. | Principal Accounting Off | F - Tax | $28.44 | -273 | 3,172 | -8% | -$7,764 |
| D | 2023-02-14 | 2023-02-10 | AGIO | Washburn Theodore James Jr. | Principal Accounting Off | M - OptEx | $0.00 | +777 | 3,445 | +29% | $0 |
| D | 2023-02-14 | 2023-02-01 | AGIO | Washburn Theodore James Jr. | Principal Accounting Off | A - Grant | $0.00 | +6,896 | 6,896 | New | $0 |
| D | 2023-02-14 | 2023-02-10 | AGIO | Washburn Theodore James Jr. | Principal Accounting Off | M - OptEx | $0.00 | -777 | 777 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2023-02-14 | F | D | 273 | $28.44 | 3,172 | D | — | — | |
| 2 | Common | Common stock | 2023-02-10 | M | A | 777 | $0.00 | 3,445 | D | — | — | (F1) Includes 119 shares purchased through the Company's employee stock purchase plan. |
| 3 | Derivative | Restricted stock units | 2023-02-01 | A | A | 6,896 | $0.00 | 6,896 | D | — · — to — | 6,896 Common stock | (F2) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F3) The restricted stock units were granted on February 1, 2023. The shares underlying the restricted stock units will vest in full on February 1, 2025. |
| 4 | Derivative | Restricted stock units | 2023-02-10 | M | D | 777 | $0.00 | 777 | D | — · — to — | 777 Common stock | (F2) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F4) The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. |